Impact of new healthcare legislation and price policy on healthcare services provider at the time of financial crisis. A 10 years study

Impact of new healthcare legislation and price policy on healthcare services provider at the time of financial crisis. A 10 years study

Authors

  • Ivona Malovecka Comenius University
  • Konstantinos Papargyris Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava. Bratislava, Slovak Republic
  • Daniela Minarikova Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava. Bratislava, Slovak Republic
  • Viliam Foltan Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava. Bratislava, Slovak Republic
  • Anezka Jankovska Department of Finance, Banking and Investment, Faculty of National Economy, University of Economics in Bratislava. Bratislava, Slovak Republic

DOI:

https://doi.org/10.7175/fe.v16i1.1040

Keywords:

Community pharmacy, Financial analysis, Corrective measures

Abstract

Monitoring, calculation and assessment of healthcare services prosperity in the community pharmacy with the help of financial analysis indicators for the years 2003-2012, using financial statements was conducted, with respect to profitability, debt, liquidity, working capital, and efficiency parameters. These ratios reflect various changes that hold between years 2003 and 2012. Under the time of financial crisis, recession and serious socio-economic changes the profitability parameter Gross Profit ranged from 2003-2011 = 16.12-22.79% (average = 19.20%; mean = 19.78%; σ = 2.41), but in 2012 decreased on 14.35%. Net Profit ranged 2003-2011 = 10.96-18.3% (average = 14.62%; mean = 16.62%; σ = 4.92), while in 2012 reached only 2.29%. Debt ratio ranged from 2003-2012= 2.33-4.81 (average = 3.44; mean = 3.07; σ = 0.82). Liquidity parameters Current Ratio spread between 2003-2012 = 1.13-1.71 (average = 1.43; mean = 1.46; σ = 0.15) and Quick Ratio spread between 2003-2012 = 0.72-1.27 (average = 1.07; mean = 1.09; σ = 0.15). Working Capital Ratio ranged from 2003-2012 = 2.66-12.94 (average = 9.58; mean = 10.06; σ = 3.1) and efficiency ratios were measured either. All changes that have taken place in the society had an impact on community pharmacy finance by worsening its profitability, liquidity, working capital and some of efficiency parameters. Therefore the stability of community pharmacy may be threatened and may affect its future performance.

Author Biography

Ivona Malovecka, Comenius University

Department of Organisation an Management in Pharmacy, assistent of professor

References

Cheng Y, Raisch DW, Borrego ME, et al. Economic, clinical and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: A literature review. Res Social Adm Pharm 2013; 9: 311-29; http://dx.doi.org/10.1016/j.sapharm.2012.05.004

Ifanti AA, Argyriou AA, Kalofonou FH, et al. Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care. Health Policy 2013; 113: 8-12; http://dx.doi.org/10.1016/j.healthpol.2013.05.017

Goranitis I, Siskou O, Liaropoulos L. Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece. Health Policy 2014; 117: 279-84; http://dx.doi.org/10.1016/j.healthpol.2014.07.012

Markovits Y, Boer D, van Dick R. Economic crisis and the employee: The effects of economic crisis on employee job satisfaction, commitment, and self-regulation. European Management Journal 2014; 32: 413-22; http://dx.doi.org/10.1016/j.emj.2013.09.005

Vogler S, Habimana K, Art D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy 2014; 117: 311-27; http://dx.doi.org/10.1016/j.healthpol.2014.06.001

Jacobs S, Schafheutle EI, Jee SD, et al. Existing arrangements for monitoring community pharmacies in England: Can they have a role in the revalidation of pharmacists? Res Social Adm Pharm 2013; 9: 166-77; http://dx.doi.org/10.1016/j.sapharm.2012.07.006

Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy’s claims to professional status in the United Kingdom. Res Social Adm Pharm 2009; 5: 305-18; http://dx.doi.org/10.1016/j.sapharm.2009.01.003

McMillan SS, Wheeler AJ, Sav A, et al. Community pharmacy in Australia: A health hub destination of the future. Res Social Adm Pharm 2013; 9: 863-75; http://dx.doi.org/10.1016/j.sapharm.2012.11.003

Norris P, Horsburgh S, Sides G, et al. Geographical access to community pharmacies in New Zealand. Health Place 2014; 29: 140-5; http://dx.doi.org/10.1016/j.healthplace.2014.07.005

Keast SL, Jacobs E, Harrison D, et al. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population. Res Social Adm Pharm 2010; 6: 209-20; http://dx.doi.org/10.1016/j.sapharm.2009.07.003

Perepelkin J, Dobson RT. Influence of ownership type on role orientation, role affinity, and role conflict among community pharmacy managers and owners in Canada. Res Social Adm Pharm 2010; 6: 280-92; http://dx.doi.org/10.1016/j.sapharm.2009.11.001

Carroll NC, Miederhoff PA, Waters LW. Profitability, third-party reimbursement, and access to community pharmacies. Clin Ther 1996; 8: 703-15; http://dx.doi.org/10.1016/S0149-2918(96)80221-9

Herist N, Rollins B, Perri M. Financial Analysis in Pharmacy Practice. London: Pharmaceutical Press, 2011

Annemans N. Health Economics for Non-Economists: An Introduction to the Concepts, Methods and Pitfalls of Health Economic Evaluations. Gent: Academia Press, 2008

Doucette WR, McDonough RP, Mormann MM, et al. Three-year financial analysis of pharmacy services at an independent community pharmacy. J Am Pharm Assoc (2003) 2012; 52: 181-7; http://dx.doi.org/10.1331/JAPhA.2012.11207

Moullin J, Sabater-Hernández D, Fernandez-Llimos F, et al. Defining professional pharmacy services in community pharmacy. Res Social Adm Pharm 2013; 9: 989-95;

http://dx.doi.org/10.1016/j.sapharm.2013.05.012

Schroeder R, Clarc M, Cathey JM. Financial Accounting Theory and Analysis. New Jersey: John Wiley & Sons, 2011

Chrisholm-Burns MA, Vaillancrt AM, Shepherd M. Pharmacy Management, Leadership, Marketing and finance. Sudbury: Jones and Barlett Publishers, 2011

Tootilian BH, Wertheimer AI, Mikhailitchenko A. Essentials of Pharmacy Management. London: Pharmaceutical Press, 2012

Aparasu RR. Research Methods for Pharmaceutical Practice and Policy. London: Pharmaceutical Press, 2011

Radford A, Mason M, Richardson I, et al. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community. Res Social Adm Pharm 2009; 5: 17-30; http://dx.doi.org/10.1016/j.sapharm.2008.04.004

Sánchez-Serrano I. The World’s Health Care Crisis. The United States’ Leadership. The World’s Health Care Crisis, London: Elsevier 2011

Matsaganis M. The Greek Crisis: Social Impact and Policy Responses. Department of Western Europe/North America, Berlin, 2013.

Söderberg IL, Wester M. Lay actions in the face of crisis—Swedish citizens’ actions in response to the global financial crisis of 2008. The Journal of Socio-Economics 2012; 41: 796-805; http://dx.doi.org/10.1016/j.socec.2012.08.007

de Belvis AG, Ferrè F, Specchia MC, et al. The financial crisis in Italy: Implications for the health care sector. Health Policy 2012, 106: 10-6; http://dx.doi.org/10.1016/j.healthpol.2012.04.003

Ásgeirsdóttir TL, Corman H, Noonan K, et al. Was the economic crisis of 2008 good for Icelanders? Impact on health behaviors. Econ Hum Biol 2014; 13: 1-19; http://dx.doi.org/10.1016/j.ehb.2013.03.005

Downloads

Published

2015-03-30

How to Cite

Malovecka, I., Papargyris, K., Minarikova, D., Foltan, V., & Jankovska, A. (2015). Impact of new healthcare legislation and price policy on healthcare services provider at the time of financial crisis. A 10 years study. Farmeconomia. Health Economics and Therapeutic Pathways, 16(1), 15–24. https://doi.org/10.7175/fe.v16i1.1040

Issue

Section

Original research

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Loading...